Darunavir - CAS# 206361-99-1 Catalog No.:M10170-2 INCB3284 exhibited a pharmacokinetic profile

INCB3284 exhibited a pharmacokinetic profile suitable for once-a-day dosing (T 1/2 = 15 h)

Smiles: C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2O

GSK-3beta is abundant in the central nervous system

Formula: C13H19Cl2NO

SD70 was administered by IP injection at 10 mg/kg once per day in xenografts model

Darunavir - CAS# 206361-99-1 Catalog No.:M10170-2 INCB3284 exhibited a pharmacokinetic profileDarunavir is a drug used to treat HIV infection. It is in the protease inhibitor class. Prezista is an OARAC recommended treatment option for treatment nave and treatment experienced adults and adolescents. Developed by pharmaceutical company Tibotec, darunavir is named after Arun K. Ghosh, the chemist who discovered the molecule at the University of Illinois at Chicago. It was approved by the Food and Drug Administration (FDA) on June 23, 2006. .